Investor Presentaiton

EQUITY TABLE Comments 154 Plus Performance RSU's (1.3M), Exercise of RSU's and Convertible Notes (000's) Total Equity and Exchangeable Shares Total Warrants Series D Q3 23 Q2 23 Change 70,184 70,030 2,180 2,180 Series C Series B Series A SPAC 1,000 1,000 10,000 10,000 2,654 2,654 30,665 30,665 Total Warrants 46,499 44,319 2,180 Stock Options 1,436 1,436 RSU's 3,209 Total 4,645 1,663 3,099 Share Price at Quarter End $ 4.55 $ 3.30 $ 1.25 Convertible Debentures Series A $ 11,895 $ 11,895 $ Series B $ 4,111 $ 4,111 $ Total $ # of Shares if converted assuming share price at quarter end 16,006 $ 3,518 16,006 $ 4,161 (643) Exercise price of $5.00 with an expiration date of August 2027 Exercise price of $5.00 with an expiration date of August 2027 Exercise price of $10.00 with an expiration date of June 2024 Exercise price of $11.50 with an expiration date of June 2026 Exercise Price between $2.26 and $4.60 with expiration dates from October 2024 to October 2026 1,546 Up to 3-year vesting through 2026 1,546 8% semi annual interest, cash or shares, higher of 10 day VWAP 5 trading days prior to pay date or $4.08, Maturity 4/15/27 8% semi annual interest, cash or shares, lower of 10 day VWAP 5 trading days prior to pay date or $10.00, Maturity 4/15/27 27

View entire presentation